LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

May 22, 2021

Primary Completion Date

February 6, 2025

Study Completion Date

February 6, 2025

Conditions
Pancreatic Neoplasms
Trial Locations (60)

D081FC00004

Research Site, Osaka

Research Site, Kanagawa

Research Site, Okayama

Research Site, Akita

Research Site, Niigata

Research Site, Shizuoka

Research Site, Niigata

Research Site, Tokyo

Research Site, Saitama

Research Site, Aichi

Research Site, Osaka

Research Site, Tokyo

Research Site, Nara

Research Site, Wakayama

Research Site, Miyagi

Research Site, Tokyo

Research Site, Osaka

Research Site, Gunma

Research Site, Tochigi

Research Site, Numakunai

Research Site, Osaka

Research Site, Shizuoka

Research Site, Nagasaki

Research Site, Kumamoto

Research Site, Saitama

Research Site, Nagano

Research Site, Hyōgo

Research Site, Shimane

Research Site, Hyōgo

Research Site, Shizuoka

Research Site, Hyōgo

Research Site, Okayama

Unknown

Research Site, Hiroshima

Research Site, Fukuoka

Research Site, Hokkaido

Research Site, Ehime

Research Site, Osaka

Research Site, Shizuoka

Research Site, Tokyo

Research Site, Aichi

Research Site, Chiba

Research Site, Fukuoka

Research Site, Gunma

Research Site, Hiroshima

Research Site, Hokkaido

Research Site, Hyōgo

Research Site, Ibaraki

Research Site, Kagawa

Research Site, Kanagawa

Research Site, Kyoto

Research Site, Nagano

Research Site, Nagasaki

Research Site, Nara

Research Site, Okayama

Research Site, Osaka

Research Site, Shizuoka

Research Site, Tokyo

Research Site, Tottori

Research Site, Toyama

Research Site, Yamagata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY